Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 469-070-1 | CAS number: 17861-60-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 24 May 2021 to 28 September 2021
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 021
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 490 (In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene)
- Version / remarks:
- 29 July 2016
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- May 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5300 - In vitro Mammalian Cell Gene Mutation Test
- Version / remarks:
- August 1998
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell gene mutation tests using the thymidine kinase gene
Test material
- Reference substance name:
- -
- EC Number:
- 469-070-1
- EC Name:
- -
- Cas Number:
- 17861-60-8
- Molecular formula:
- C9H26O2Si3
- IUPAC Name:
- 4-ethyl-2,2,4,6,6-pentamethyl-3,5-dioxa-2,4,6-trisilaheptane
- Test material form:
- liquid
- Remarks:
- Clear colourless liquid
Constituent 1
- Specific details on test material used for the study:
- Storage conditions: Room temperature in the dark
Method
- Target gene:
- thymidine kinase, TK
- Metabolic activation:
- with and without
- Metabolic activation system:
- The S9 mix was prepared by mixing S9 with 100 mM phosphate buffer containing NADP (5 mM), G6 P (5 mM), KCl (33 mM) and MgCl2 (8 mM) to give a 20% S9-mix concentration. The final concentration of S9 when dosed at a 10% volume of S9-mix was 2% for the Preliminary Toxicity Test and the Mutagenicity Tests.
- Test concentrations with justification for top dose:
- Mutagenicity test (+S9,-S9/both 4 hours): 0; 3.91; 7.81; 15.63; 31.25; 62.5; 125; 250; 500
Due to the expected precipitate of the test item not being observed at the end of the exposure period, this experiment was abandoned prior to plating.
Mutagenicity Test Repeat I (+S9, -S9): 0, 7.81, 15.63, 31.25, 62.5, 125, 250, 500, 1000
Due to the mutant frequency of mid-range dose levels exceeding the Global Evaluation Factor (GEF) in the 4-hour exposure group in the absence of metabolic activation, a repeat of this exposure group was performed as Mutagenicity Test Repeat III to confirm or disprove the responses observed. A repeat of the 4-hour exposure group in the presence of metabolic activation was performed as Mutagenicity Test Repeat II in error. Initially it was considered that the acceptability criteria had not been met when in fact it had.
Mutagenicity Test Repeat II (+S9/4hours): 0,7.81, 15.63, 31.25, 62.5, 125, 250, 500, 1000
Due to the experiment being performed in error, this experiment was abandoned prior to plating.
Mutagenicity Test Repeat III (-S9): 0, 15.63, 31.25, 62.5, 93.75, 125, 187.5 - Vehicle / solvent:
- Acetone
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- Presence of S9 mix
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- Absence of S9 mix
- Details on test system and experimental conditions:
- Preliminary toxicity test:
A preliminary toxicity test was performed on cell cultures at 5 x 10E5 cells/mL, using a 4-hour exposure period both with and without metabolic activation (S9). The dose range used in the preliminary toxicity test was 3.91 to 1000 µg/mL. The maximum concentration was the maximum practical concentration. Following the exposure periods the cells were washed twice with R10, resuspended in R20 medium, counted and then serially diluted to 2 x 10E5 cells/mL. The cultures were incubated at 37 °C with 5% CO2 in air and sub-cultured after 24 hours by counting and diluting to 2 x 10E5 cells/mL. After a further 24 hours, the cultures were counted and then discarded. The cell counts were then used to calculate Suspension Growth (SG) values. The SG values were then adjusted to account for immediate post exposure toxicity, and a comparison of each exposure SG value to the concurrent solvent control performed to give a percentage Relative Suspension Growth (%RSG) value. Results from the preliminary toxicity test were used to set the test item concentrations for the mutagenicity experiments.
Mutagenicity Tests:
Several days before starting each experiment, an exponentially growing stock culture of cells was set up so as to provide an excess of cells on the morning of the experiment. The cells were counted and processed to give 1 x 10E6 cells/mL in 10 mL aliquots in R10 medium in sterile plastic universals for the 4-hour exposure groups in both the absence and presence of metabolic activation, where applicable. The exposures were performed in duplicate (A + B), both with and without metabolic activation (2% S9 final concentration), where applicable, at eight concentrations of the test item and solvent and positive controls. To each universal was added 2 mL of S9-mix if required, 0.1 mL of the exposure dilutions, (0.2 mL or 0.15 mL for the positive controls), and sufficient R0 medium to bring the total volume to 20 mL.
The concentrations of test item used were 3.91 to 500 µg/mL in the Main Experiment, 7.81 to 1000 µg/mL for the Main Experiment Repeat I and Repeat II, and 7.81 to 250 µg/mL in the Main Experiment Repeat III. During exposure to the test item cultures were shaken continuously. - Evaluation criteria:
- Assessments:
- Measurement of Survival, Cloning Efficiency and Mutant Frequency;
- Plate scoring;
- Calculation of Percentage Relative Suspension Growth (%RSG);
- Calculation of Cloning Efficiency (%V);
- Calculation of Relative Total Growth (RTG);
- Calculation of Mutant Frequency (MF). - Statistics:
- Not performed.
Results and discussion
Test results
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Main Experiment Repeat I: Precipitate of test item was observed at and above 250 µg/mL at the end of the exposure period in both the absence and presence of metabolic activation. The test item did not induce any increases in the mutant frequency at any of the concentrations in the presence of metabolic activation test that exceeded the Global Evaluation Factor (GEF), using a dose range that included the lowest precipitating concentration, and at least four analysable concentrations, as recommended by the OECD 490 guideline. The mean mutant frequencies for the test item treated cultures were all within the laboratory 95% control limits of historical solvent control data. The results observed in the presence of metabolic activation were considered to fulfil the criteria for a clearly negative outcome. Increases in mutant frequency that did exceed the GEF were observed mid-dose range in the absence of metabolic activation. The increases in mutant frequency observed exceeded 95% control limits of historical solvent control data, and were statistically significant but not concentration-related when evaluated with a trend test.
Main Experiment Repeat III: Precipitate of test item was observed at and above 187.5 µg/mL at the end of the exposure period in the absence of metabolic activation. The test item did not induce any increases in the mutant frequency at any of the concentrations in the absence of metabolic activation test that exceeded the Global Evaluation Factor (GEF), using a dose range that included the lowest precipitating concentration, and at least four analysable concentrations, as recommended by the OECD 490 guideline. The statistically significant increases observed in the previous experiment were therefore considered to be spurious and of no toxicological significance.
Applicant's summary and conclusion
- Conclusions:
- In an In Vitro Mammalian Cell Gene Mutation Test, performed according to OECD/EC guidelines and GLP principles, the test item did not induce any toxicologically significant increases in the mutant frequency at the TK +/- locus in L5178Y cells, consequently it is considered to be non-mutagenic in this assay.
- Executive summary:
The mutagenicity potential of 3-Ethylheptamethyltrisiloxane was assessed according to the OECD 490 guideline “In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene”.
The test item concentrations ranged from 0 to 1000 μg/mL in the two main experiments. Acetone was used as a solvent and negative control. Cells were exposed to the test item and negative control for a period of 4 hours in both presence and absence of S9 mix.
The solvent control cultures had mutant frequency values that were acceptable for the L5178Y cell line at the TK +/- locus. The positive controls produced marked increases in the mutant frequency per viable cell achieving the acceptability criterion.
The test item was tested up to and exceeding precipitating concentrations and did not induce any increases in the mutant frequency at any of the concentrations in the absence of metabolic activation test that exceeded the Global Evaluation Factor (GEF), using a dose range that included the lowest precipitating concentration, and at least four analysable concentrations. The mean mutant frequencies for the test item treated cultures were all within the laboratory 95% control limits of historical solvent control data. The results observed in the absence of metabolic activation were considered to fulfil the criteria for a clearly negative outcome.
In main experiment I, increases in mutant frequency that did exceed the GEF were observed mid-dose range in the absence of metabolic activation. The increases in mutant frequency observed were statistically significant but were not concentration-related when evaluated with a trend test.
The statistically significant increases observed in the Main experiment I were considered to be spurious and of no toxicological significance as the same was not observed in the repeat experiment.
Under the conditions of this study, 3-Ethylheptamethyltrisiloxane did not induce any toxicologically significant increases in the mutant frequency at the TK +/- locus in L5178Y cells that exceeded the GEF, consequently it is considered to be non-mutagenic in this assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.